Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vβ16 T-lymphocyte activation

Virology

Volumn 287, Issue 2, 2001, Pages 321-332

  Perron, H ^a,b   Jouvin Marche, E ^c   Michel, M ^b   Ounanian Paraz, A ^b   Camelo, S ^d   Dumon, A ^d   Jolivet Reynaud, C ^a   Marcel, F ^a,b   Souillet, Y ^a,b   Borel, E ^c   Gebuhrer, L ^e   Santoro, L ^a   Marcel, S ^f   Seigneurin, J M ^b   Marche, P N ^c   Lafon, M ^d  

^a Centre d'Immunologie Pierre Fabre   (France)

^b Laboratoire De Virologie   (France)

^c INSERM   (France)

^d INSTITUT PASTEUR   (France)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

^f HÔPITAL MICHALLON   (France)

Author keywords

Cytokines; Endogenous retrovirus; Envelope protein; HERV W; Immunopathology; MSRV; Multiple sclerosis; Superantigen; T cell receptor; T lymphocyte

Indexed keywords

HLA DR ANTIGEN; RECOMBINANT PROTEIN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IN VITRO STUDY; MULTIPLE SCLEROSIS; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE ACTIVATION; VIRION; VIRUS ENVELOPE; VIRUS PARTICLE; VIRUS RECOMBINANT;

HUMAN ENDOGENOUS RETROVIRUS W; MULTIPLE SCLEROSIS ASSOCIATED RETROVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 17944369083     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1045     Document Type: Article

References (56)

1. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation
2. Epstein-Barr virus and multiple sclerosis
3. TCR repertoire and cytokine profiles of cerebrospinal fluid- and peripheral blood-derived T lymphocytes from patients with multiple sclerosis
4. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family
5. Multiple sclerosis susceptibility: Population and twin study of polymorphisms in the T-cell receptor beta and gamma genes region
6. T cell receptor beta chain genotyping in Australian relapsing-remitting multiple sclerosis patients
7. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes
8. Dual virus etiology of age-dependent poliomyelitis of mice. A potential model for human motor neuron diseases
9. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production
10. Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack
11. Immunotherapy by non-myeloablaative stem cell transplantation: Study of the immune reconstitution in two cases. Arguments for distinct cell subsets in skin and blood
12. Genetic resistance to a retroviral neurologic disease in wild mice
13. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis
14. Enhancement of TAT-induced transactivation of the HIV-1 LTR by two genomic fragments of HHV-6
15. The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirus
16. A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease
17. Just another dubious virus in cells from a patient with multiple sclerosis?
18. Lack of restriction of T cell receptor beta variable gene usage in cerebrospinal fluid lymphocytes in acute optic neuritis
19. Configuration and expression of the T cell receptor beta chain gene in human T-lymphotrophic virus I-infected cells
20. Chromosome 7 long arm deletion breakpoints in preleukemia: Mapping by pulsed field gel electrophoresis
21. Chromosome 7 long-arm deletions in myeloid disorders: Terminal DNA sequences are commonly conserved and breakpoints vary
22. Chromosome 7 long arm deletion in myeloid disorders: A narrow breakpoint region in 7q22 defined by molecular mapping
23. Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles
24. Multiple sclerosis and human T-cell lymphotropic retroviruses
25. Evidence for a viral superantigen in humans
26. Establishment of a human malignant T lymphoma cell line carrying retrovirus-like particles with RT activity
27. Functional analysis of the env open reading frame in human endogenous retrovirus IDDMK(1,2)22 encoding superantigen activity
28. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K
29. T-cell receptor J beta 1/J beta 2 locus rearrangements in an HTLV-1-positive T-cell lymphoma with complex chromosomal aberrations
30. Cytomegalovirus as a co-factor of disease progression in human immunodeficiency virus type 1 infection
31. T cell receptor V genes in multiple sclerosis: Increased use of TCRAV8 and TCRBV5 in MBP-specific clones
32. Retroviral RNA related to ERV9/MSRV in a human serum: A new sequence variant
33. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments
34. Microbial agents triggering endogenous retroviruses within genetic susceptibility loci, resulting in expression of superantigen and gliotoxic molecules: A plausible "immunovirogenetic" cascade causing multiple sclerosis?
35. Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: Possible components of a "chain-reaction" triggered by infectious agents in multiple sclerosis?
36. Cell cultures and associated retroviruses in multiple sclerosis
37. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis
38. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis
39. Isolations of an unknown retrovirus from CSF, blood and brain from patients with multiple sclerosis
40. Isolation of retrovirus from patients with multiple sclerosis
41. Do endogenous retroviruses have etiological implications in inflammatory and degenerative nervous system diseases?
42. Does a retrovirally encoded superantigen cause multiple sclerosis?
43. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA
44. Inversion of chromosome 7 in ataxia telangiectasia is generated by a rearrangement between T-cell receptor beta and T-cell receptor gamma genes
45. Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells
46. V beta activation by HIV Nef protein: Detection by a simple amplification procedure
47. Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family
48. Involvement of a human endogenous retroviral sequence (THE-7) in a t(7;14)(q21;q32) chromosomal translocation associated with a B cell chronic lymphocytic leukemia
49. Association between clinical disease activity and Epstein-Barr virus reactivation in MS
50. Chlamydia pneumoniae-induced transactivation of the major immediate early promoter of cytomegalovirus: Potential synergy of infectious agents in the pathogenesis of atherosclerosis
51. The V beta-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice
52. A potential role for human herpesvirus type 6 in nervous system disease
53. The T-cell receptor beta locus and susceptibility to multiple sclerosis
54. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression
55. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene
56. Activation and clonal expansion of human myelin basic protein-reactive T cells by bacterial superantigens